Skip to content
GLP-1 Scorecard
Menu
Site position #212

Eve

Published by GLP-1 ScorecardUpdated

Eve is a women's-health-focused GLP-1 telehealth platform — distinctive positioning in a largely gender-neutral market — offering both compounded semaglutide and tirzepatide (including an oral sublingual form) and brand-name Ozempic, Wegovy, and Mounjaro on one account.

Visit EveWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$195/mo (compounded)
Tirzepatide
$195/mo (compounded)
Coverage
Coverage not published
Brand-name
Yes

Weigh Eve against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value55/100
Dose & formulation88/100
Clinical oversight79/100
Labs & monitoring52/100
Fulfillment67/100
Contract terms41/100

Strengths

  • Genuinely women's-health-focused — fills a real gap among gender-neutral GLP-1 competitors
  • Both compounded and brand-name FDA-approved options (Wegovy/Ozempic/Mounjaro) on one platform — rare
  • Publishes the FDA compounded-medication disclaimer
  • Oral sublingual semaglutide offered alongside injectable

What to consider

  • Full states-served list not disclosed publicly
  • 503A pharmacy partner not named, and 503A vs 503B status not specified
  • Named medical director / clinical leadership not disclosed
  • Corporate legal entity not disclosed
  • Governing law / arbitration venue not stated

Bottom line — Grade C

Best for: Shoppers who want women's-health GLP-1 with compounded or brand-name access.

Site position #212 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Visit Eve

Closest here

The rankings grading nearest Eve — the realistic shortlist.

NextMeds#215

NextMeds is a cash-pay telehealth platform offering compounded semaglutide and compounded tirzepatide on a flat monthly membership — one price bundling the medication (if prescribed), telehealth visits, a 1:1 care coach, and a licensed registered dietitian, with free shipping and no insurance.

Queen RX#216

Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo).

TOM Weight Loss#217

Solo-physician DTC telemedicine clinic in Texas + Utah operated by Dr. Tran Le, MD (ABOM-board-certified obesity medicine, ABPM-certified addiction + occupational medicine, NPI 1194212258).

Coivas#218

Coivas is an all-inclusive GLP-1 telehealth service operated by WellVi LLC (d/b/a Coivas) with prescriptions through Arora Health & Aesthetics, LLC.

Revel Health#219

Revel Health is a telehealth platform combining GLP-1 weight loss with longevity care — semaglutide and tirzepatide plus NAD+, sermorelin and peptide therapy — prescribed by board-certified physicians and compounded in USP 795/800-compliant facilities.

10rx#222

10rx advertises $297 semaglutide and $447 tirzepatide quarterly base plans. Named care and pharmacy partners improve the comparison, but pharmacy choice, full-term commitments and refund limits matter before paying.

The 18 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Eve's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Eve's site. Not medical advice; see our disclosure.

← Back to the scorecard